On December 18, 2020, Benson Hill Biosystems, Inc. closed the transaction. The company announced that it has amended the terms of the transaction and has now raised $159,088,252 in the transaction. The transaction included participation of 21 investors.

The company received $9,088,249 in its final tranche.